The University City Science Center?s QED Program awarded a total of $600,000 Wednesday to two digital health projects and two life science projects.
The funds will go to researchers at Rutgers University, the University of Delaware, and Penn State College of Medicine, who will also get to consult with the programs business advisers about commercializing their technology.
Digital Health Projects to get $100,000 funding included a technology that can enhance the identification of prostate cancer through computer-based image analysis of MRI scans, which being developed by Dr. Anant Madabhushi?s team at Rutgers University and Case Western Reserve University; and a smartphone app to support physical therapy for stroke patients, which is being developed by Dr. William Craelius of Rutgers University, and co-invented by Nicky Newby of Nian-Crae Inc. of Somerset, N.J.
The two $200,000 awards made to life science technologies are a potential drug therapy for prostate cancer, developed from a novel class of compounds by Drs. Robert Sikes and John Koh at the University of Delaware; and an?eye drop therapy for diabetic retinopathy, being developed by Dr. Joyce Tombran-Tink of Penn State College of Medicine.
For each award, half of the funds come from the QED program and half are contributed by the awardee institution.
Since its launch in 2009, the regionally competitive proof-of-concept program supporting technology commercialization has awarded $3 million to 16 projects in Pennsylvania, New Jersey and Delaware.
The QED Program reviewed 56 digital health and life science proposals from 11 universities in the fifth funding round.
Beat: Health Care, Biotech/Pharmaceutical, Sports
Samsung Galaxy S3 linkedin linkedin usps bachelor pad bachelor pad Green Coffee Bean Extract
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.